
Sign up to save your podcasts
Or


Rewinding the ticker tape. Jim Roppel, founder of the Roppel Report, joins the “Investing with IBD” podcast to share his analysis of the panic bottom, strategies for removing hedges and the signals he’s seeing of a quiet bull case building in the market. Learn about the drug development potential of Eli Lilly (LLY), the bull case in Nvidia (NVDA) and why Cava (CAVA) is in a class of its own.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Investor's Business Daily4.5
366366 ratings
Rewinding the ticker tape. Jim Roppel, founder of the Roppel Report, joins the “Investing with IBD” podcast to share his analysis of the panic bottom, strategies for removing hedges and the signals he’s seeing of a quiet bull case building in the market. Learn about the drug development potential of Eli Lilly (LLY), the bull case in Nvidia (NVDA) and why Cava (CAVA) is in a class of its own.
Learn more about your ad choices. Visit megaphone.fm/adchoices

4,100 Listeners

3,228 Listeners

1,366 Listeners

938 Listeners

518 Listeners

1,982 Listeners

357 Listeners

298 Listeners

356 Listeners

2,145 Listeners

1,573 Listeners

212 Listeners

830 Listeners

73 Listeners

53 Listeners